Shares of Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) gapped up before the market opened on Friday. The stock had previously closed at $103.76, but opened at $110.30. Pro Medicus shares last traded at $110.30, with a volume of 10 shares traded.
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group downgraded Pro Medicus from a “buy” rating to a “hold” rating in a research report on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Pro Medicus has a consensus rating of “Hold” and an average price target of $155.00.
Check Out Our Latest Stock Analysis on Pro Medicus
Pro Medicus Stock Performance
About Pro Medicus
Pro Medicus Limited is an Australian medical technology company that develops software for medical imaging and healthcare organizations. Its primary product is the Visage enterprise imaging platform, which supports the storage, management, viewing and distribution of diagnostic images such as X-rays, CT scans and magnetic resonance images.
The company’s software is designed to help hospitals, radiology practices and other healthcare providers manage imaging workflows and enable clinicians to access diagnostic information across locations.
Read More
- Five stocks we like better than Pro Medicus
- Arista Networks Plugs Into All-Time Highs
- Microsoft Is Almost Back to $555—Now the Hard Part Begins
- Marvell Says Connecting AI Chips Could Be a $37 Billion Business—These 2 Stocks Rallied Too
- JetBlue’s LaGuardia Win Could Change Its Financial Future
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
